Sialic acids as regulators of molecular and cellular interactions

Current Opinion in Structural Biology

Volumn 19, Issue 5, 2009, Pages 507-514

  Schauer, Roland ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BETA1 INTEGRIN; CERAMIDE; FAS ANTIGEN; GALECTIN; GALECTIN 3; GANGLIOSIDE GD3; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; N GLYCOLOYLNEURAMINIC ACID; NERVE CELL ADHESION MOLECULE; PROTEIN TYROSINE KINASE A; SELECTIN; SIALIC ACID; SIALIDASE;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CELL INTERACTION; EMBRYO DEVELOPMENT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREGULATION; MOLECULAR INTERACTION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIALYLATION; SYNAPTOGENESIS; TUMOR IMMUNITY; VIRUS CELL INTERACTION;

ANIMALS; ANTIGENS; HUMANS; INFLAMMATION; LIGANDS; LYMPHOCYTES; SIALIC ACIDS;

ANIMALIA; EUKARYOTA; MAMMALIA; PROKARYOTA; SIA;

EID: 70349878950     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2009.06.003     Document Type: Review

References (53)

1. In: Kamerling J.P., Boons G.-J., Lee Y.C., Suzuki A., Taniguchi N., and Voragen A.G.J. (Eds). Comprehensive Glycoscience-From Chemistry to Systems Biology vols. 1-4 (2007), Elsevier, Oxford. This multiauthor, well-edited book series comprises all aspects of structure, analysis, chemical and biochemical synthesis, catabolism, molecular biology and cell biological, and pathophysiological aspects of complex carbohydrates. The reader's attention is drawn to the following chapters: Kobata A: Glycoprotein glycan structures, vol. 1, 39-72; Yu RK, Yanagisawa M, Ariga T: Glycosphingolipid structures, vol. 1, 73-122; Miyagi T, Yamaguchi K: Sialic acids, vol. 3, 297-323.
2. Royle L., Matthews E., Corfield A., Berry M., Rudd P.M., Dwek R.A., and Carrington S.D. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J 25 (2008) 763-773
3. Varki A. Sialic acids in human health and disease. Trends Mol Med 14 (2008) 351-360
4. Janas T., and Janas T. Polysialic acids: structure and properties. In: Dumitriu S. (Ed). Polysaccharides - Structural Diversity and Functional Versatility. edn 2 (2005), Marcel Dekker, New York 707-727
5. von Itzstein M., and Thomson R. Anti-influenza drugs: the development of sialidase inhibitors. In: Kräusslich H.-G., and Bartenschlager R. (Eds). Antiviral Strategies. Handbook Exp Pharmacol vol. 189 (2009), Springer-Verlag, Berlin, Heidelberg 111-154
6. Varki A., and Schauer R. Sialic acids. In: Varki A., Cummings R.D., Esko J.D., Freeze H.H., Stanley P., Bertozzi C.R., Hart G.W., and Etzler M.E. (Eds). Essentials of Glycobiology (2009), Cold Spring Harbor Laboratory Press, New York 199-217
7. Kontou M., Weidemann W., Bork K., and Horstkorte R. Beyond glycosylation: sialic acid precursors act as signaling molecules and are involved in cellular control of differentiation of PC12 cells. Biol Chem 390 (2009) 575-579
8. Cummings R., and Liu F.-T. Galectins. In: Varki A., Cummings R.D., Esko J.D., Freeze H.H., Stanley P., Bertozzi C.R., Hart G.W., and Etzler M.E. (Eds). Essentials of Glycobiology (2009), Cold Spring Harbor Laboratory Press, New York 475-487. In addition to this article describing various galectins and their functions it is recommended to turn also to other chapters of the Section "Glycan-Binding Proteins" of this book and to corresponding chapters of Ref. [1].
9. Kerfoot S.M., McRae K., Lam F., McAvoy E.F., Clark S., Brain M., Lalor P.F., Adams D.H., and Kubes P. A novel mechanism of erythrocyte capture from circulations in humans. Exp Hematol 36 (2008) 111-118
10. Grewal P.K., Uchiyama S., Ditto D., Varki N., Le D.T., Nizet V., and Marth J.D. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 14 (2008) 648-655. The paper reports an important function of the Ashwell Gal-recognizing receptor: it retards the onset and impairs the severity of disseminated intravascular coagulation during sepsis and thus favors survival of the host by trapping desialylated thrombocytes.
11. Carlin A.F., Uchiyama S., Chang Y.-C., Lewis A.L., Nizet V., and Varki A. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil siglec-9 and dampen the innate immune response. Blood 113 (2009) 3333-3336. Sialylated capsular polysaccharide of group B Streptococcus engages siglec-9 of neutrophils and in this way impairs the defense functions of these white blood cells. A reduction of the neutrophil oxidative burst, diminished formation of neutrophil extracellular DNA traps, and increased bacterial survival were observed.
12. Schauer R. The diversity of sialic acids and their interplay with lectins. In: Sansom C., and Markman O. (Eds). Glycobiology (2007), Scion Publ. Ltd., Bloxham 136-149
13. Woronowicz A., Amith S.R., De Vusser K., Laroy W., Contreras R., Basta S., and Szewczuk M.R. Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase. Glycobiology 17 (2006) 10-24
14. Nightingale T.D., Frayne M.E.F., Clasper S., Banerji S., and Jackson D.G. A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium. J Biol Chem 284 (2009) 3935-3945
15. Zhuo Y., Chammas R., and Bellis S.L. Sialylation of β1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem 283 (2008) 22177-22185
16. Lee M., Lee H.-J., Bae S., and Lee Y.-S. Protein sialylation by sialyltransferase involves radiation resistance. Mol Cancer Res 6 (2008) 1316-1325. Ionizing radiation stimulated the expression of ST6GalI followed by increased protein sialylation, especially cell membrane integrin β1. This is an important observation and the resulting higher tumor resistance to radiation should be considered during cancer treatment.
17. Schauer R, Srinivasan GV, Wipfler D, Kniep B, Schwartz-Albiez R: O-Acetylated sialic acids and their role in immune defense. In Molecular Immunology of Complex Carbohydrates-3 (MICC-3), Edited by Wu AM. Adv Exp Med Biol, Kluwer Academic/Plenum Publishers, New York; 2009, in press.
18. Nimmerjahn F., Anthony R.M., and Ravetch J.V. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci U S A 104 (2007) 8433-8437. IgG antibodies contain a branched glycan residue at the asparagine residue 297 of the Fc portion, which is essential for maintaining a functional Fc structure. Antibody activity is much influenced by variation of the glycan composition. Patients with autoimmune disorders, for example rheumatoid arthritis, have increased levels of antibodies lacking terminal Sia and Gal residues. Antibodies with high levels of terminal Sia show reduced affinity to cellular receptors and have anti-inflammatory effects. Accordingly, Sia seem to be crucial regulators of antibody activity in vivo, thus reducing inflammatory reactions.
19. Mühlenhoff M., Oltmann-Norden I., Weinhold B., Hildebrandt H., and Gerardy-Schahn R. Brain development needs sugar: the role of polysialic acid in steering NCAM functions. Biol Chem 390 (2009) 567-574
20. Hildebrandt H., Mühlenhoff M., Weinhold B., and Gerardy-Schahn R. Dissecting polysialic acid and NCAM functions in brain development. J Neurochem 103 Suppl 1 (2007) 56-64
21. Rutishauser U. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat Rev Neurosci 9 (2008) 26-35
22. Conboy L., Bisaz R., Markram K., and Sandi C. Role of NCAM in emotion and learning. Neurochem Res (2008) 10.1007/s11064-008-9601-4
23. Chang L.-Y., Mir A.-M., Thisse C., Guérardel Y., Delannoy P., Thisse B., and Harduin-Lepers A. Molecular cloning and characterization of the expression pattern of the zebrafish α2,8-sialyltransferases (ST8Sia) in the developing nervous system. Glycoconj J 26 (2009) 263-275
24. Steenbergen S.M., and Vimr E.R. Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment. Mol Microbiol 68 (2008) 1252-1267
25. Byrne B., Donohoe G.G., and O'Kennedy R. Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today 12 (2007) 319-326
26. Lehmann F., Tiralongo E., and Tiralongo J. Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 63 (2006) 1331-1354
27. Yao L., Korteweg C., Hsueh W., and Gu J. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J 22 (2008) 733-740
28. Kumari K., Gulati S., Smith D.F., Gulati U., Cummings R.D., and Air G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 4 (2007) 42-53
29. Loo Y.-M., and Gale Jr. M. Fatal immunity and the 1918 virus. Nature 445 (2007) 267-268
30. Neu U., Woellner K., Gauglitz G., and Stehle T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Natl Acad Sci U S A 108 (2008) 5219-5224
31. Lindén S.K., Wickström C., Lindell G., Gilshenan K., and Carlstedt I. Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter 13 (2008) 81-93
32. Yang J.-C., Shun C.-T., Chien C.-T., and Wang T.-H. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice. J Nutr 138 (2008) 2084-2090. Helicobacter pylori infection of cell cultures and mice was considerably reduced or prevented by combined application of sialyllactose and catechins, which hinder binding of the bacteria and diminish oxidative stress, respectively. In this connection, see Ref. [31].
33. Yoneyama T., Miyata K., Chikai T., Mikami A., Suzuki T., Hasegawa K., Ikeda T., Watanabe T., Ohyama T., and Niwa K. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid. FEMS Immunol Med Microbiol 54 (2008) 290-298
34. Byres E., Paton A.W., Paton J.C., Löfling J.C., Smith D.F., Wilce M.C.J., Talbot U.M., Chong D.C., Yu H., Huang S., et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456 (2008) 648-652
35. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446 (2007) 1023-1029
36. Varki A., and Angata T. Siglecs - the major subfamily of I-type lectins. Glycobiology 16 (2006) 1R-27R
37. Carlin A.F., Lewis A.L., Varki A., and Nizet V. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol 189 (2007) 1231-1237
38. Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J 26 (2009) 231-245
39. Crocker P.R., Paulson J.C., and Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 7 (2007) 255-266
40. Abdu-Allah H.H.M., Tamanaka T., Yu J., Zhuoyuan L., Sadagopan M., Adachi T., Tsubata T., Kelm S., Ishida H., and Kiso M. Design, synthesis, and structure - affinity relationships of novel series of sialosides as CD22-specific inhibitors. J Med Chem 51 (2008) 6665-6681
41. McMillan S.J., and Crocker P.R. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease. Carbohydr Res 343 (2008) 2050-2056
42. Quarles R.H. Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem 100 (2007) 1431-1448
43. Taylor M.E., and Drickamer K. Paradigms for glycan-binding receptors in cell adhesion. Curr Opin Cell Biol 19 (2007) 572-577
44. Thomas W.E. Mechanochemistry of receptor-ligand bonds. Curr Opin Struct Biol 19 (2009) 50-55
45. x epitopes, only the former of which was found to bind to selectin.
46. Padler-Karavani V., Yu H., Cao H., Chokhawala H., Karp F., Varki N., Chen X., and Varki A. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 18 (2008) 818-830. Normal human serum contains a diverse spectrum of anti-Neu5Gc antibodies, directed against the xenoantigen Neu5Gc, most likely derived from food. Since this observation may have severe clinical implications, this publication will greatly stimulate further, especially clinical, investigations. See Ref. [34]: Neu5Gc mediates human susceptibility to Shiga toxin.
47. Lehmann F., Kelm S., Dietz F., von Itzstein M., and Tiralongo J. The evolution of galactose α2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galβ1,3GalNAc structures on glycoproteins but not glycolipids. Glycoconj J 25 (2008) 323-334
48. Lrhorfi L.A., Srinivasan G.V., and Schauer R. Properties and partial purification of sialate-O-acetyltransferase from bovine submandibular glands. Biol Chem 388 (2007) 297-306
49. Bergfeld A.K., Claus H., Lorenzen N.K., Spielmann F., Vogel U., and Mühlenhoff M. The polysialic acid-specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases. J Biol Chem 284 (2009) 6-16. In mutagenesis studies of this O-acetyltransferase that belongs to the α/β-hydrolase fold family a catalytic triad composed of Ser-286, Asp-376, and His-399 was discovered. A covalent acetyl-enzyme intermediate is formed on catalysis.
50. Miyagi T. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad, Ser B 84 (2008) 407-418
51. Chavas L.M.G., Tringali C., Fusil P., Venerando B., Tettamanti G., Kato R., Monti E., and Wakatsuki S. Crystal structure of the human cytosolic sialidase Neu2. J Biol Chem 280 (2005) 469-475
52. Schwarzer D., Stummeyer K., Haselhorst T., Freiberger F., Rode B., Grove M., Scheper T., von Itzstein M., Mühlenhoff M., and Gerardy-Schahn R. Proteolytic release of the intramolecular chaperone domain confers processivity to endosialidase f. J Biol Chem 284 (2009) 9465-9474
53. Schauer R., and Shukla A.K. Isolation and properties of two sialate-O-acetylesterases from horse liver with 4- and 9-O-acetyl specificities. Glycoconj J 25 (2008) 625-632